IQOS and SELETTI Join Forces for Milan Design Week: Celebrating Design, Innovation, and a Smoke-Free Future
As Philip Morris International (PMI, NYSE: PM) continues its steadfast journey toward a smoke-free world, the company recently unveiled an exciting collaboration with the esteemed Italian design brand, SELETTI, during Milan Design Week. The collaboration, dubbed Curious X: Sensorium Piazza, showcases a unique installation that exemplifies innovation, creativity, and a commitment to a new era of tobacco consumption alternatives.
A Groundbreaking Installation
Set within the vibrant confines of Opificio 31 at Tortona Rocks, the Curious X: Sensorium Piazza installation invites visitors to experience a sensory exploration that challenges traditional perceptions of tobacco use and celebrates the shift towards modern, harm-reduction products. By joining forces with SELETTI, a brand renowned for its whimsical yet elegant designs, IQOS aims to blend aesthetics with purpose. This installation embodies the essence of reimagining tobacco experiences and highlights the transformative power of design in everyday life.
The choice of location is significant; Tortona Rocks is a hub of creativity and innovation during Milan Design Week, attracting a diverse audience passionate about design, art, and culture. This environment embodies the crossroads of lifestyle and technology that IQOS champions as part of its strategy to appeal to contemporary consumers seeking better alternatives to traditional smoking.
Supporting a Smoke-Free Future
The collaboration is part of PMI s broader mission to create a smoke-free future, advocating for PM With over 32 million users globally, IQOS is at the forefront of this transformation. The collaboration with SELETTI serves not only as a celebration of this community but also as a pivotal moment to engage a new audience with a fresh narrative surrounding tobacco products.
A Broader Commitment to Harm Reduction
In tandem with this exciting initiative at Milan Design Week, PMI recently received FDA authorization for the modified risk designation of Swedish Match’s General snus products. This authorization allows Swedish Match to communicate its reduced exposure claims to adult smokers and users of traditional tobacco products. The FDA s decision underscores the continuing trend of regulatory bodies recognizing harm-reduction strategies in tobacco consumption. The agency s conclusion reaffirms that General snus can provide reduced risks relative to smoking, supporting PMI s overall aim to reduce harm caused by tobacco use.
Expanding Horizons in Healthcare
In an additional move aligned with its vision to enhance public health, PMI s affiliate, Vectura Fertin Pharma, has announced the sale of its subsidiary, Vectura Group, to Molex Asia Holdings Ltd. This strategic decision will allow Vectura Fertin Pharma to focus on its core competencies in inhaled therapeutics, a promising area that could revolutionize how consumers access healthcare solutions.
Conclusion
The collaboration between IQOS and SELETTI at Milan Design Week represents more than just an engaging installation; it symbolizes PMI s ongoing commitment to innovation, harm reduction, and the future of tobacco alternatives. By integrating design with purpose, PMI is inviting the world to rethink the tobacco experience and foster a healthier lifestyle. As the company navigates regulatory landscapes and explores new frontiers in healthcare, it continues to position itself as a leader in the industry, paving the way for a smoke-free future.
By bridging the worlds of design and health, PMI, through IQOS, is crafting a narrative that resonates with a diverse audience, ultimately aiming to create a culture in which smoking becomes a relic of the past.
Comments